Analyst firms · Citigroup · AXP
Citigroup AXP price target and rating history
American Express Company (AXP) · Finance
Citigroup rates American Express Company (AXP) Neutral with a $250 price target, as of its latest action on Jun 10, 2024. It has published 4 rating actions on AXP since July 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a AXP price target in the last 12 months, the median target is $384.50.
- Current rating
- Neutral
- Price target
- $250
- Median target, all firms
- $384.50
- Actions on AXP
- 4
Citigroup price target on AXP
Every Citigroup rating on AXP
- Jun 10, 2024
- Oct 25, 2023
- Oct 13, 2022
- Jul 9, 2021
How other firms rate AXP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $380 | Oct 9, 2026 |
| Piper Sandler | Overweight | $396 | Jun 30, 2026 |
| DZ Bank | Buy | $375 | Jun 18, 2026 |
| Loop Capital | Buy | $389 | May 22, 2026 |
| Wolfe Research | Peer Perform | Dec 8, 2025 |
Questions about Citigroup and AXP
- What is Citigroup's price target for AXP?
- Citigroup's latest stated price target for American Express Company (AXP) is $250, from its action on Jun 10, 2024.
- What is Citigroup's rating on AXP?
- Citigroup rates AXP Neutral, a neutral rating, as of Jun 10, 2024.
- When did Citigroup last change its view on AXP?
- On Jun 10, 2024, Citigroup starts coverage at Neutral, price target $250.
- How does Citigroup's AXP target compare with other analysts?
- Across 4 firms with a AXP price target in the last 12 months, the median target is $384.50.
More AXP rating histories
- BMO Capital Markets4
- Piper Sandler4
- DZ Bank4
- Monness, Crespi, Hardt9
- Rothschild & Co Redburn3
- BofA Securities4
- Robert W. Baird4
- J.P. Morgan4
- Barclays8
- Morgan Stanley7
- Deutsche Bank4
- Stephens5
- RBC Capital Markets3
- Oppenheimer3
All Citigroup ratingsAXP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.